Jeffery Ash
Family · Port Huron, MINPI 1346892502
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $691 and has fallen 77.5% since, to $155 in 2024.
Across 106 payments — averaging $14.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$347
- Novo Nordisk$264
- Pfizer$154
- GSK$109
- Biohaven Pharmaceuticals, Inc.$102
- Boehringer Ingelheim$100
- plus $461 from 18 others
What the payments were for
- Food & beverage$1,537100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $347 |
| Novo Nordisk | 22 | $264 |
| Pfizer | 8 | $154 |
| GSK | 7 | $109 |
| Biohaven Pharmaceuticals, Inc. | 6 | $102 |
| Boehringer Ingelheim | 5 | $100 |
| Amarin Pharma, Inc. | 4 | $71 |
| Bayer | 2 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $35 |
| Novartis | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Avion Pharmaceuticals | 1 | $27 |
| Johnson & Johnson | 2 | $26 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| Seqirus USA Inc | 1 | $19 |
| Exact Sciences | 1 | $18 |
| AstraZeneca | 1 | $16 |
| Merck | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Amgen | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Xeris Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,537 in reported general payments places this provider in the 75th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 12 | $4,294 |
| Orphenadrine Citrate ErOrphenadrine Citrate | 14 | $600 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $587 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $578 |
| Ondansetron OdtOndansetron | 20 | $351 |
| Atorvastatin Calcium | 23 | $320 |
| Tamsulosin Hcl | 15 | $317 |
| Ketorolac Tromethamine | 11 | $204 |
| Cephalexin | 34 | $204 |
| Famotidine | 17 | $183 |
| Montelukast Sodium | 11 | $183 |
| Amlodipine Besylate | 16 | $168 |
| Prednisone | 46 | $152 |
| Furosemide | 15 | $151 |
| Ondansetron Hcl | 11 | $144 |
Paid to pharmacies, not to this prescriber.
Other family in Port Huron
- Carol HillikerPort Huron$13K
- Danielle SabalaPort Huron$11K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.